Sunday, September 18, 2005

Important safety information on Duragesic (fentanyl transdermal system)

From Health Canada:
Janssen-Ortho Inc., in collaboration with Health Canada, wishes to highlight important safety information about the safe use of DURAGESIC. The Canadian Product Monograph for DURAGESIC has been revised to emphasize this safety information, and contains a section with Consumer Information to ensure that patients and their caregivers are aware of the guidelines for the safe use of DURAGESIC. For the public...

Janssen-Ortho Inc., in consultation with Health Canada, wishes to highlight certain important safety information for the safe and appropriate prescribing and use of DURAGESIC* (fentanyl transdermal system). For health professionals...

No comments: